Home » Pharmaceuticals
Pfizer to Tie the Knot with Allergan in Deal Worth $160 Billion
Pfizer and fellow drug maker Allergan announced Monday morning that they would be merging in a huge deal of $160 billion that would create the largest drug maker in the world, producing treatments that vary from Botox to Lipitor. The... More of this article »
Valeant Drops Mail-Order Pharmacy Philidor
Valeant Pharmaceuticals International a maker of drugs, whose practices of aggressive pricing have helped it become a lightning rod for much criticism, announced on Friday it was ending a relationship it had with a pharmacy it used... More of this article »
Antipsychotic Long Lasting Drug Approved by FDA
The U.S. Food and Drug Administration has approved a new drug for schizophrenia by Alkermes PLC a biotech company in Ireland with executives based in Waltham. The new drug, Aristada, is a longer acting version of Abilify an antipsychotic... More of this article »
Teva Acquires Rimsa the Pharmaceutical Company in Mexico
Teva Pharmaceuticals Industries will acquire Representacions e Investigaciones Medicas a pharmaceutical manufacturing as well as distribution company based in Mexico and known commercially as Rimsa. This deal includes a large portfolio... More of this article »
WHO Calls For Early HIV Drug Treatment for All
Everyone who has HIV should receive antiretroviral drugs as early as possible following their diagnosis, which means over 37 billion people globally, should be receiving the treatment said the (WHO) World Health Organization on Wednesday. Recently... More of this article »
Collegium Painkiller Given Green Light from FDA Panel
The experimental opioid painkiller by Collegium Pharmaceutical has moved another step closer to FDA approval after a panel of expert advisers to the United States Food and Drug Administration voted unanimously in favor of its painkiller. The... More of this article »
Vital Therapies Stock Plunges Following Failed Trial For Liver Therapy
Vital Therapies Inc lost nearly 75% of its market value on Friday after the company announced that its therapy for the liver failed to reach its main goal in a recent late-stage study, which raised doubts about the treatment’s future. The... More of this article »
Endo International Revenue and Earnings Beat Targets
Endo International on Monday posted adjusted earnings that were better than had been expected during its second quarter, as the sales were given a boost from its recent acquisitions, although its discontinued operation hit its bottom... More of this article »
Allergen Bid Might Be Better for Teva
Following months of battling in its hostile takeover bid for Mylan, its rival, Teva Pharmaceutical’s move to acquire Allergan’s generic drug segment might instead be a smoother course that could bring in bigger and faster returns. Teva,... More of this article »
Biogen Slashes Forecast on Weakness of Tecfidera
Biogen Inc announced on Friday that it has slashed its outlook for revenue and earnings for the full year as its growth in sales for its multiple sclerosis drug is still weakening. Biogen said it expects to have earnings per share... More of this article »
Celgene Investing $1 Billion in Juno Therapeutics
Juno Therapeutics shares soared on Tuesday a day after Celgene a bigger drug developer announced its plans to invest close to $1 billion in the company mostly through purchases of stock as part of a new collaboration to develop autoimmune... More of this article »
Bayer Sells Diabetes Care to Panasonic Healthcare
Bayer entered into an agreement with Panasonic Healthcare Holdings to sell its Diabetes Care company. Panasonic Holdings is backed by the Panasonic Corp and KKR and the sales price it has agreed to pay is $1.15 billion, said company... More of this article »
Valeant Nearing Deal to Acquire Salix for $10 Billion
Valeant Pharmaceuticals, the drug maker based in Canada is closing in a deal to purchase Salix Pharmaceuticals the gastrointestinal drug maker for an estimated $10 billion. A deal, said those close to the situation, could be announced... More of this article »
AstraZeneca Acquiring Respiratory Drug Segment from Actavis
AstraZeneca announced it was paying $600 million for the rights to the brand respiratory drugs segment of Actavis in North America, as the drug maker reported a drop in profits for the fourth quarter that was steeper that was expected. The... More of this article »
Merck & Co Acquiring Cubist Pharmaceuticals
Merck & Co is set to acquire antibiotics maker Cubist Pharmaceuticals in a deal that is estimated to be between $7 billion and $8 billion. A report cited a source that said Merck would pay Cubist close to $102 a share with an official... More of this article »
Actavis Close to Deal to Acquire Allergan for $64 Billion
Actavis Plc is near a deal to acquire Allergan Inc for an estimated $64 billion, a deal that would help the Botox maker rebuff the hostile advance of Valeant Pharmaceuticals International, said people that have knowledge of the deal. A... More of this article »
Eli Lilly Earnings Meet Expectations
Eli Lilly & Company reported adjusted earnings for the third quarter of 66 cents per share that were in line with estimates on Wall Street but were 41% lower than earnings from the same period one year ago. Revenue for the third... More of this article »
Horizon Pharma Moves Overseas Defying Lawmakers
Despite an increasing amount of criticism from Washington lawmakers, a drug maker officially left the U.S. and opened its corporate offices in Ireland in a move that was designed to lower its taxes. Horizon Pharma closed its acquisition... More of this article »
Roche Acquires InterMune
Roche the pharmaceutical giant based in Switzerland is expanding its treatments for respiratory disease through its acquisition of InterMune a drug maker in Brisbane for more than $8.3 billion, said both companies. Roche agreed to... More of this article »
Sanofi to Market Afrezza the Inhaled Insulin Medication
Sanofi, a pharmaceutical company in France, has agreed to purchase the right to market Afrezza for $925 million. The drug was recently approved as an inhaled insulin treatment for diabetics that was developed by California based MannKind... More of this article »
Roche to Acquire Seragon in U.S. for $1.7 Billion
Roche Holding AG announced that it would spend as much as $1.725 billion to purchase Seragon Pharmaceuticals, a U.S. biotech privately held company that researches treatments for breast cancer. Roche for very a long period of time... More of this article »
AbbVie Bid for Shire Rejected as Low
Shire Plc has rejected a takeover bid of 27.3 million pounds or $46.5 million from AbbVie Inc as too low. This is the most recent attempt by a healthcare company from the U.S. to lower its corporate taxes by relocating to the United... More of this article »
Ex-Glaxo Chief in China Caught Up in Bribery Allegations
On Wednesday, China accused the former chief to GlaxoSmithKline in China of ordering his staff to commit bribery that resulted in revenue in the billions of yuan. Officials from the Ministry of Public Security in China at a briefing... More of this article »
Bayer AG Acquiring Consumer Business from Merck
Bayer AG, based in Germany, is acquiring the consumer business of Merck for an estimated $14.2 billion. Bayer will now be the owners of brands that are well known including Afrin, Coppertone and Claritin. The deal means the German... More of this article »
Pfizer Reports Weaker Profits
Pfizer Inc the United States based pharmaceutical giant said its profit in the first quarter shrank by 15% due to weaker revenue in both of its largest businesses. The U.S. drug maker did not comment when it released its earnings about... More of this article »
AstraZeneca Offered $100 Billion by Pfizer
AstraZenca, the Anglo-Swedish pharmaceutical company saw it shares spike by 15% Monday after Pfizer the U.S. pharmaceutical giant said it had offered the company close to $100 billion to buy it. Pfizer, which is the maker of the famous... More of this article »
CVS Caremark Profit Increase by 12% in Fourth Quarter
Shares at CVS Caremark outpaced Tuesday’s broader market after the pharmacy chain increased its forecast for earnings for the beginning of 2014 and reassured its investors that its business could absorb the hit financially that was... More of this article »
GlaxoSmithKline Stops Paying Doctors for Promotion of Drugs
GlaxoSmithKline the British pharmaceutical giant announced on Tuesday that it was stopping its payments to doctors who speak on behalf of the company. GSK also announced that pay for sales representatives would not be tied to how many... More of this article »
Shire to Acquire ViroPharma for $4.2 Billion
Shire, based in Dublin announced on Monday that it had agreed to acquire ViroPharma for $4.2 billion to expand its rare disease treatments portfolio. The company said it agreed to pay $50 a share for the Pennsylvania based ViroPharma,... More of this article »
Johnson & Johnson to Pay Penalty of $2.2 Billion
Johnson & Johnson agreed it would pay over $2.2 billion in order to settle civil and criminal claims that it had marketed Risperdal, its antipsychotic drug as well as other medications for uses off-label and paid large kickbacks... More of this article »
Pfizer Beats Wall Street Estimates
Pfizer, Inc., the biggest drug maker in the world reported profits for the third quarter that passed the estimates of analysts as the drug maker lowered its costs, while its sales of its top painkiller and vaccine increased. Earnings... More of this article »
Profit Falls at Merck on Lower Sales
Merck and Co’s earnings for the third quarter dropped by 35% as it lost the exclusivity for Singulair the allergy and asthma drug that contributed to the pharmaceutical giant’s weaker sales. Merck said expenses related to the restructuring... More of this article »
Actelion Reaches High of Six Years
Actelion the Swiss biotech company saw its shares climb over 5% to their highest since 2007 on Monday. Its stock prices increased on optimism that it had a viable product to gain sales and earn profit after an approval in the U.S.... More of this article »
Executives of British Drug Maker Investigated for Bribes
The police in China announced on Monday that British pharmaceutical giant GlaxoSmithKline had channeled millions of dollars worth of bribes through travel agents in China to doctors and government officials. The bribes helped GSK to... More of this article »
Hospital Chain Tenet Acquires Vanguard Health
Tenet Healthcare, a US hospital operator, announced that it will acquire its rival Vanguard Health Systems for $1.73 billion. It would give it a better position to benefit from President Barack Obama’s healthcare reform. Investors... More of this article »
Tenet Acquiring Vanguard Health in Deal for $1.8 Billion
Vanguard Health Systems, a hospital operator, will be acquired by Tenet Healthcare Corp, for an estimated $1.8 billion so Tenet can expand into more hospitals in Texas. The deal will have Tenet paying $21 per share, said the companies... More of this article »
Actavis to acquire Warner Chilcott
Actavis, the generic drug maker, has been talked about over speculation of being taken over, is planning to buy Ireland’s Warner Chilcott the specialty pharmaceutical firm for a price of $5 billion. Both companies announced the deal... More of this article »
Healthcare Sector Leads Wall Street Increase
Stocks increased Tuesday, which was headed by the healthcare sector. The rally came after the government announced its decision on payment rates. Investors also felt optimistic after the release of the report on factory orders that... More of this article »
Justice Department Settles Online Pharmacy Probe with UPS
The U.S. Justice Department announced it had reached an agreement for $40 million Friday to settle charges against UPS that the giant shipping company had done business with Internet pharmacies that were illegal. U.S. officials agreed... More of this article »
Pharmaceuticals Give Large Sums of Money to Physicians
Most patients are unaware that different pharmaceutical companies give doctors thousands of dollars for each patient that they enrol in experimental drug trials. Even though the motive’s of the doctor’s may be pure and the medications... More of this article »
Profit at Merck Falls in Fourth Quarter
Merck, the pharmaceutical giant based in Whitehouse Station, New Jersey, announced that profits fell in the fourth quarter of 2012 by 7%. Company officials said that was due in part to sales of Singulair, its best selling asthma medication,... More of this article »
FDA Approves New Use for Pfizer Vaccine
Pfizer received approval from the U.S. Food and Drug Administration on Friday to use Prevnar 13 in children and adolescents between the age of 6 and 17 to prevent Invasive Pneumococcal Disease. Prevnar 13 becomes the first and just... More of this article »
Johnson & Johnson Diabetes Drug Gets Advisory Board Approval
On Thursday, a new drug being developed by Johnson & Johnson was given backing by an advisory panel that voted 10 to 5 in favor of recommending the drug to the U.S. Food and Drug Administration. If approved, the drug would be the... More of this article »
Anti-Clotting Drug Approved by FDA
Eliquis, the anti-clotting drug by Bristol-Myers Squibb and Pfizer was approved on Friday by the U.S. Food and Drug Administration. The FDA approval had been long anticipated by many cardiologists and is considered the next blockbuster... More of this article »
Draftfcb Healthcare Acquires Hudson Global, Retains Management Team
Interpublic Group (NYSE:IPG) subsidiary Draftfcb Healthcare announced today that they are acquiring N.Y.-based pharmaceutical marketing company Hudson Global which offers integrated marketing solutions aimed at the pharmaceutical industry. Hudson... More of this article »
Jazz Pharma (JAZZ) Wraps Up EUSA Pharma Acquisition
Jazz Pharmaceuticals (NASDAQ:JAZZ) has announced that they have wrapped up their acquisition of privately-held EUSA Pharma for $680 million in cash and notes it is accretive to their earnings and expect incremental modified EPS of... More of this article »
Omnicell (OMCL) Completes MTS Medication Tech Bid
Omnicell, Inc., (NASDAQ:OMCL) announced today it has completed its acquisition of MTS Medication Technologies, Inc., which the company had previously stated on May 2nd, 2012 that it intended to do. Randall Lipps, chairman, president... More of this article »
OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology
OriGene Technologies, Inc. announced today the acquisition of Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd (ZsBio). Founded in the year 1993, ZsBio provides testing products (pathology) within their domestic Chinese market,... More of this article »